BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/24/2024 8:35:39 AM | Browse: 85 | Download: 267
 |
Received |
|
2023-10-25 09:17 |
 |
Peer-Review Started |
|
2023-10-25 09:18 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-01-05 23:43 |
 |
Revised |
|
2024-01-20 13:14 |
 |
Second Decision |
|
2024-02-28 02:48 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-02-28 07:41 |
 |
Articles in Press |
|
2024-02-28 07:41 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2024-03-06 04:39 |
 |
Typeset the Manuscript |
|
2024-04-15 06:22 |
 |
Publish the Manuscript Online |
|
2024-04-24 08:35 |
ISSN |
1948-5182 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Infectious Diseases |
Manuscript Type |
Review |
Article Title |
Spectrum of COVID-19 induced liver injury: A review report
|
Manuscript Source |
Invited Manuscript |
All Author List |
Lokjan Singh, Anil Kumar, Maya Rai, Bibek Basnet, Nishant Rai, Pukar Khanal, Kok-Song Lai, Wan-Hee Cheng, Ahmed Morad Asaad and Shamshul Ansari |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Shamshul Ansari, MSc, PhD, Assistant Professor, Health Sciences, Abu Dhabi Women's College, Higher Colleges of Technology, Abu Dhabi 41012, United Arab Emirates. shamshulansari483@yahoo.com |
Key Words |
Autoimmune liver disease; COVID-19; Clinical manifestation of liver; Drug-induced liver injury; SARS-CoV-2 |
Core Tip |
The coronavirus disease 2019 (COVID-19) pandemic has imposed an unprecedented burden on public health and healthcare globally. It can decompensate pre-existing liver disease or induce acute liver injury. Its presence in hepatocytes directly exhibits cytopathic action, and damages the liver because of hypoxia, inflammation, and medication toxicity. The pathophysiology of COVID-19-related liver involvement includes viral cytotoxicity, immunological dysregulation's secondary effect, hypoxia brought on by respiratory failure, ischemia damage from vascular endotheliitis, heart failure, or drug-induced liver injury. This study focuses on the pathophysiology, available treatments, and outcomes of liver injury in relation to COVID-19. |
Publish Date |
2024-04-24 08:35 |
Citation |
Singh L, Kumar A, Rai M, Basnet B, Rai N, Khanal P, Lai KS, Cheng WH, Asaad AM, Ansari S. Spectrum of COVID-19 induced liver injury: A review report. World J Hepatol 2024; 16(4): 517-536 |
URL |
https://www.wjgnet.com/1948-5182/full/v16/i4/517.htm |
DOI |
https://dx.doi.org/10.4254/wjh.v16.i4.517 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345